Literature DB >> 15150260

The T cell receptor gamma chain alternate reading frame protein (TARP), a prostate-specific protein localized in mitochondria.

Hiroshi Maeda1, Satoshi Nagata, Curt D Wolfgang, Gary L Bratthauer, Tapan K Bera, Ira Pastan.   

Abstract

We previously showed that mRNA encoding TARP (T cell receptor gamma chain alternate reading frame protein) is exclusively expressed in the prostate in males and is up-regulated by androgen in LNCaP cells, an androgen-sensitive prostate cancer cell line. We have now developed an anti-TARP monoclonal antibody named TP1, and show that TARP protein is up-regulated by androgen in both LNCaP and MDA-PCa-2b cells. We used TP1 to determine the subcellular localization of TARP by Western blotting following subcellular fractionation and immunocytochemistry. Both methods showed that TARP is localized in the mitochondria of LNCaP cells, MDA-PCa-2b cells, and PC-3 cells transfected with a TARP-expressing plasmid. We also transfected a plasmid encoding TARP fused to green fluorescent protein into LNCaP, MDA-Pca-2b, and PC-3 cells and confirmed its specific mitochondrial localization in living cells. Fractionation of mitochondria shows that TARP is located in the outer mitochondrial membrane. Immunohistochemistry using a human prostate cancer sample showed that TP1 reacted in a dot-like cytoplasmic pattern consistent with the presence of TARP in mitochondria. These data demonstrate that TARP is the first prostate-specific protein localizing in mitochondria and indicate that TARP, an androgen-regulated protein, may act on mitochondria to carry out its biological functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150260     DOI: 10.1074/jbc.M402492200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma.

Authors:  Melissa Rotunno; Nan Hu; Hua Su; Chaoyu Wang; Alisa M Goldstein; Andrew W Bergen; Dario Consonni; Angela C Pesatori; Pier Alberto Bertazzi; Sholom Wacholder; Joanna Shih; Neil E Caporaso; Phil R Taylor; Maria Teresa Landi
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-08

Review 2.  Immunotherapy in prostate cancer: emerging strategies against a formidable foe.

Authors:  Marijo Bilusic; Christopher Heery; Ravi A Madan
Journal:  Vaccine       Date:  2011-07-07       Impact factor: 3.641

3.  Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, TARP.

Authors:  Hiroya Kobayashi; Toshihiro Nagato; Kensuke Oikawa; Keisuke Sato; Shoji Kimura; Naoko Aoki; Ryusuke Omiya; Masatoshi Tateno; Esteban Celis
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

4.  Expression of POTE protein in human testis detected by novel monoclonal antibodies.

Authors:  Tomoko Ise; Sudipto Das; Satoshi Nagata; Hiroshi Maeda; Yoomi Lee; Masanori Onda; Miriam R Anver; Tapan K Bera; Ira Pastan
Journal:  Biochem Biophys Res Commun       Date:  2007-11-09       Impact factor: 3.575

5.  Novel methods to identify biologically relevant genes for leukemia and prostate cancer from gene expression profiles.

Authors:  Austin H Chen; Yin-Wu Tsau; Ching-Heng Lin
Journal:  BMC Genomics       Date:  2010-04-30       Impact factor: 3.969

Review 6.  [Immunohistochemical algorithms in prostate diagnostics: what's new?].

Authors:  G Kristiansen
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

7.  Molecular characterization of the feline T-cell receptor γ alternate reading frame protein (TARP) ortholog.

Authors:  Alexander Th A Weiss; Marie-Charlotte von Deetzen; Werner Hecht; Manfred Reinacher; Achim D Gruber
Journal:  J Vet Sci       Date:  2012-12       Impact factor: 1.672

8.  Detecting cancer outlier genes with potential rearrangement using gene expression data and biological networks.

Authors:  Mohammed Alshalalfa; Tarek A Bismar; Reda Alhajj
Journal:  Adv Bioinformatics       Date:  2012-06-28

9.  Tumor-associated antigens for specific immunotherapy of prostate cancer.

Authors:  Andrea Kiessling; Rebekka Wehner; Susanne Füssel; Michael Bachmann; Manfred P Wirth; Marc Schmitz
Journal:  Cancers (Basel)       Date:  2012-02-22       Impact factor: 6.639

10.  TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.

Authors:  Barbara Depreter; Karin E Weening; Karl Vandepoele; Magnus Essand; Barbara De Moerloose; Maria Themeli; Jacqueline Cloos; Diana Hanekamp; Ine Moors; Inge D'hont; Barbara Denys; Anne Uyttebroeck; An Van Damme; Laurence Dedeken; Sylvia Snauwaert; Glenn Goetgeluk; Stijn De Munter; Tessa Kerre; Bart Vandekerckhove; Tim Lammens; Jan Philippé
Journal:  Haematologica       Date:  2019-08-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.